Nuvicare Headache Relief Tablet
FDA Label NDC 84324-007

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Nuvicare Llc for the product Nuvicare Headache Relief (NDC 84324-007). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding active ingredients  (in each caplet), purpose, uses:, warnings:, ask doctor:, ask doctor/pharmacist:, pregnancy, directions, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Inactive Ingredients

Colloidal Silicon Dioxide, Hypromellose, Microcrystalline Cellulose, Polyethylene Glycol, Pregelatinized Starch, Polyvinyl Pyrrolidone, Stearic Acid Powder, Talc.

* Please review the disclaimer below.